Sage Journals: Discover world-class research

Open access

Research article

First published 2019

Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts

Francesca Ricci, Laura Brunelli, Roberta Affatato [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2016-12

Overexpression of MAC30 is Resistant to Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer

Ruhua Chen, Yan Fen, Xubo Lin [...]

Technology in Cancer Research & Treatment

Open access

Case report

First published 2022

Exceptional response to lurbinectedin and irinotecan in BRCA -mutated platinum-resistant ovarian cancer patient: a case report

Laura Cortesi, Marta Venturelli, Elena Barbieri [...]

Sage Open Chronic Disease

Retricted access

Research article

First published 2010-11

Positive experience of Intraperitoneal Chemotherapy followed by Intravenous Chemotherapy in Heavily Pretreated Patients with Suboptimal Residual Ovarian Cancer and Primary Peritoneal Cancer

Maria Ornella Nicoletto, Maurizia Dalla Palma, Martin E Donach [...]

Tumori Journal

Retricted access

Research article

First published 2010-11

Positive experience of Intraperitoneal Chemotherapy followed by Intravenous Chemotherapy in Heavily Pretreated Patients with Suboptimal Residual Ovarian Cancer and Primary Peritoneal Cancer

Maria Ornella Nicoletto, Maurizia Dalla Palma, Martin E Donach [...]

Tumori Journal

Open access

Research article

First published 2019

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

Alexandre Sostelly, François Mercier

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 1999-7

A Phase I-II Trial of High-dose Ifosfamide in Patients with Ovarian Cancer Refractory or Resistant to Platinum and/or Paclitaxel-containing Chemotherapy

Giovanna Scarfone, Antonella Villa, Fabio Parazzini [...]

Tumori Journal

Open access

Research article

First published 2023

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models

Gwo Yaw Ho, Cassandra J. Vandenberg, Ratana Lim [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas

Roberta Affatato, Michela Chiappa, Federica Guffanti [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2018

A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet

Hope Cottrill, Stephanie Cason, Scott Caroen [...]

Journal of Investigative Medicine High Impact Case Reports

Search results